Myocardial Solutions, Inc. (MSI) announces opening of first MyoStrain Cardiac Prevention Center in conjunction with Nuestra Señora del Rosario in Madrid, Spain. The hospital has initiated an online “direct to patient” program to inform patients with chronic diseases, or long COVID that MyoStrain®...
Myocardial Solutions (MSI) announced today the hiring of Gary Brock as its new President. Previously serving on the MSI Board of Directors and as a commercialization consultant, Mr. Brock will now take the lead in initiating and building relationships between MSI and hospital networks to....
A new study featuring Myocardial Solutions’ software, MyoStrain, was published as a part of the PREFECT research project. The purpose of this study was to determine how to improve personalized treatment for patients undergoing cancer therapy. Patient quality of life and cardiac status....
A recent study expanded on the value of MyoStress® during needle-free stress testing inpatients with coronary artery disease (CAD), using another non-pharmacologic stress method: dynamic handgrip exercise (DHE). DHE may have the potential to address...
This article addresses the importance of having a new tool like MyoStrain® to detect patients with preserved Left Ventricle Ejection Fraction (LVEF). Traditional diagnostic metrics...
